Clinical trial
Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102
NCT07527975 is registered in ClinicalTrials.gov with Rocket Pharmaceuticals Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102
- Lead sponsor
- Rocket Pharmaceuticals Inc.
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- February 1, 2022
- Completion date
- May 31, 2038
- Enrollment
- 14 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.